We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Animalcare Group Plc | LSE:ANCR | London | Ordinary Share | GB0032350695 | ORD 20P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 217.00 | 214.00 | 220.00 | 217.00 | 217.00 | 217.00 | 8,272 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Service-livestock | 71.62M | 1.97M | 0.0327 | 66.36 | 130.41M |
From Apr 2019 to Apr 2024
TIDMANCR
RNS Number : 9215B
Animalcare Group PLC
25 September 2018
25 September 2018
Animalcare Group plc
("Animalcare", the "Company" or the "Group")
Dividend declaration for the six months ended 30 June 2018
Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, is pleased to announce that it will pay an interim dividend of 2.0 pence per ordinary share on 23rd November 2018 to shareholders whose names are on the Register of Members at close of business on 26th October 2018. The ordinary shares will become ex-dividend on 25th October 2018.
For further information, please contact:
Hot Features
Premium
Animalcare Group plc Tel: 01904 487 687
Chris Cardon, Chief Executive Officer
Panmure Gordon (Nominated Adviser Tel: 020 7886 2500
& Broker)
Corporate Finance
Freddy Crossley / Emma Earl
Corporate Broking
James Stearns
Consilium Strategic Communications animalcare@consilium-comms.com
Amber Fennell / Chris Welsh / Hendrik
Thys
About Animalcare (www.animalcaregroup.co.uk)
Animalcare Group plc is a UK AIM listed veterinary sales, marketing and product development company resulting from the merger of Animalcare and Ecuphar NV.
Post-merger Animalcare is a pan-European animal health company, with a broad geographic footprint. The Company now has direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany) and exports to approximately 50 markets worldwide.
The enlarged Company has nearly 100 sales representatives and 28 agents operating across Europe and owns 50 licensed drugs, eight vaccines and over 100 care and nutraceutical products.
Animalcare invests in developing its own pharmaceutical products, seeks distribution partnerships and product acquisitions.
For more information see Animalcare Ltd (www.animalcare.co.uk) and Ecuphar NV (www.ecuphar.com).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DIVLAMFTMBJTBAP
(END) Dow Jones Newswires
September 25, 2018 12:36 ET (16:36 GMT)
1 Year Animalcare Chart |
1 Month Animalcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
